By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Cardiovascular BioTherapeutics, Inc. 

1700 W. Horizon Ridge Parkway, Suite 100

Henderson  Nevada    U.S.A.
Phone: 714-368-1520 Fax: 714-368-1517


SEARCH JOBS








Company News
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Interim Board of Directors Remains in Place 6/24/2013 9:46:37 AM
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Shareholders Vote for Change 6/10/2013 9:55:05 AM
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Engages Auditors for 2008 Through 2011 SEC Reporting 6/28/2011 8:02:40 AM
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Submits FDA Application for 'Fast Track' Status for CVBT-141B, CVBT's Biological Treatment for Diabetes Patients 2/3/2011 9:58:48 AM
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Announces Diabetic Wounds Drug Phase II Clinical Trial Data 1/4/2011 6:41:39 AM
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Licenses Phase II Diabetic Wound Healing Data From Cardiovascular BioTherapeutics, Inc. (CVBT.OB) 11/30/2010 9:00:16 AM
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Opens Florida and Arizona Sites for Its ACORD Phase II Heart Trial 2/24/2009 10:56:20 AM
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Opens Two Additional Sites for Its ACORD Phase II Heart Trial 1/8/2009 9:09:51 AM
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Opens Two Additional Sites for Patient Enrollment for Phase II Heart Trial 12/11/2008 8:13:45 AM
Cardiovascular BioTherapeutics, Inc. (CVBT.OB) Doses First Patient in its Phase II Clinical Trial for Severe Coronary Heart Disease 11/25/2008 9:45:30 AM
1234567
//-->